Teva Announces Approval of a Generic Version of Forteo® (teriparatide injection), in the U.S. | Business Wire
How the U.S. Compares to Europe on Biosimilar Approvals and Products In the Pipeline Updated March 14, 2022 | Biosimilars Law Bulletin
Teva Pharma is the way to play the re-rise of generic drugs
Teva Raises Guidance Amid Generics Growth :: Generics Bulletin
Lilly faces biosimilar rivals to osteoporosis drug Forsteo in Europe | pharmaphorum
Strides Says Forsteo Biosimilar 'Significant Product', Seeks New Minority Investor In Stelis :: Scrip
Teva Announces Approval of a Generic Version of Forteo® (teriparatide injection), in the U.S. -November 17, 2023 at 08:31 am EST | MarketScreener
Alvogen inks deals for Forteo biosimilar in South Korea, Israel and Ca
Pfenex: The First U.S. Forteo Biosim And A Host Of Other Biosims In Pipeline (NYSEMKT:PFNX) | Seeking Alpha
Stada Arz in-licenses teriparatide, expanding its biosimilars portfoli
Teriparatide - Wikipedia
How the U.S. Compares to Europe on Biosimilar Approvals and Products In the Pipeline Updated March 14, 2022 | Biosimilars Law Bulletin
Teva's Research Pipeline to Culminate in Many New Drug Launches?
Apotex And Ambio Shatter Hopes Of Teriparatide Exclusivity For Teva :: Generics Bulletin
Teva Announces Approval of a Generic Version of Forteo® (teriparatide injection), in the U.S.
Teva Announces Approval of a Generic Version of Forteo® (teriparatide injection), in the U.S. | TEVA Stock News
biosimilars
Pfenex: The First U.S. Forteo Biosim And A Host Of Other Biosims In Pipeline (NYSEMKT:PFNX) | Seeking Alpha
Hitting A Moving Target: Teva's Dethlefs Discusses US Complex Generics :: Generics Bulletin
Teva announces approval of a generic version of Forteo in US
EMA's Biosimilar List Includes Drugs Also Under FDA's Scrutiny
